바이오로직스 자료
Whitepapers
Navigating biopharmaceutical complexity: embracing quality-by-design for enhanced development strategies
The implementation of a Quality-by-Design (QbD) approach enables drug developers to construct more robust processes and analytical methods, resulting in high-quality pharmaceuticals. This whitepaper explores how we thoroughly manage sources of variability inherent in the process and mitigate risks to support streamlined and standardized production.
The implementation of a Quality-by-Design (QbD) approach enables drug developers to construct more robust processes and analytical methods, resulting in high-quality pharmaceuticals. This whitepaper explores how we thoroughly manage sources of variability inherent in the process and mitigate risks to support streamlined and standardized production.